Nanobiotix S.A. (NBTX) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nanobiotix Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.859 day and thank you for standing by. Welcome to the Nanobiotics Full Year 2025 00:00:05.859 -- 00:00:10.886 Financial Results Conference Core. At this time, all participants 00:00:10.886 -- 00:00:15.953 are in a listen-only mode. After the speaker's presentation, there will be 00:00:15.953 -- 00:00:21.000 a question and answer session. To ask a question during the session, you will 00:00:21.000 -- 00:00:23.984 need to press star 1, 1 on your telephone. 00:00:23.984 -- 00:00:29.832 You will then hear an automated message advising your hand is raised. 00:00:29.832 -- 00:00:34.958 To withdraw your question, please press star 1, 1 again. 00:00:34.958 -- 00:00:38.943 Please be advised that today's conference is being recorded. 00:00:38.943 -- 00:00:43.588 I would now like to hand the conference over to your speaker today, Joanne Choi, Head 00:00:43.588 -- 00:00:47.273 of Investor Relations U.S. Please go ahead. 00:00:47.273 -- 00:00:50.256 Thank you, Heidi. Good afternoon and good morning. 00:00:50.256 -- 00:00:55.322 And welcome to the Nanobiotics Conference Call to discuss our full year 2025 00:00:55.322 -- 00:00:56.864 financial 00:00:56.864 -- 00:01:01.994 and operational results. Joining me on the call today are Laurent Levy, co-founder 00:01:01.994 -- 00:01:07.160 and chief executive officer, and Bart Van Ryn, chief financial and business 00:01:07.160 -- 00:01:13.267 officer. Today's call is being webcast and will be available on our website for replay. 00:01:13.267 -- 00:01:17.352 Before we begin, I would like to remind you that today's discussion will include four 00:01:17.352 -- 00:01:21.636 looking statements within the meaning of applicable securities laws. 00:01:21.636 -- 00:01:23.859 These statements are based 00:01:23.859 --...